InvestorsHub Logo
Followers 8
Posts 1816
Boards Moderated 0
Alias Born 07/31/2021

Re: justdafactss post# 209564

Friday, 05/27/2022 10:22:07 AM

Friday, May 27, 2022 10:22:07 AM

Post# of 231474
Yep, also looks like the market was not impressed by the mTNBC data presented at ASCO. The facts remain that zero revenue is coming in and millions are owed to Samsung and Amarex with no way to pay them. Of course, the SEC and DOJ investigations are still looming and there is a disclaimer at the top of every page on cytodyn's website:

On February 11, 2022, CytoDyn, Inc. received a Warning Letter from the U.S. Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion in which FDA asserted that statements made in a video created a misleading impression regarding the safety and efficacy of leronlimab. Leronlimab is an investigational drug that has not been approved (or authorized) by the U.S. FDA for the treatment of COVID-19 or for any indication. For more information, click here to access a Dear Healthcare Provider (DHCP) Letter: View Here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News